MDCL

Medicine Man Technologies Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 3/22/2017
Contact Info
  • 4880 Havana Street
  • Suite 102 South
  • Denver, CO 80239

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001622879
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8742 - Management consulting services
Incorporated In: NV, USA
Year of Inc. 2014
Employees 12 a/o Mar 01, 2017
Company Officers/Contacts
Charley Haupt General Director
Andrew Johns Williams CEO, Other
Brett Edward Roper COO, Other
Paul Daniel Dickman CFO
Company Directors
Brett Edward Roper Chairman
James Sylvester Toreson Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Andrew Johns Williams
Service Providers
Accounting/Auditing Firm
BF Borgers CPA PC
5400 West Cedar Avenue
Lakewood, CO, 80226
United States
 
Securities Counsel
Andrew I Telsey, Esq.
12835 E. Arapahoe Road, Tower One,
Suite 803
Englewood, CO, 80112-55427
United States
 
Investor Relations Firm

Not Available
MDCL Security Details
Share Structure
Market Value1 $30,163,415 a/o Mar 24, 2017
Authorized Shares 90,000,000 a/o Mar 01, 2017
Outstanding Shares 17,435,500 a/o Mar 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,885,100 a/o Mar 10, 2017
Par Value 0.001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders
Shareholders of Record 2,150 a/o Jan 31, 2017
Short Selling Data
Short Interest 3,577 (183.89%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security